Featured News
Press Release
Alzheimer’s Advocates Turn House Budget Hearings Purple, Building Bipartisan Momentum for Access to FDA-Approved Alzheimer’s Treatments
Alzheimer’s Association and Advocates Urge HHS Secretary to Cover Alzheimer’s Treatments Washington, D.C., March 29, 2023 — Alzheimer’s Association advocates put on their purple and came together i...
All News
Press Release
Critical Legislation to Renew National Commitment to Fighting Alzheimer’s Reintroduced in Congress
NAPA Reauthorization Act and Alzheimer’s Accountability and Investment Act Washington, D.C., January 31, 2023 — The Alzheimer’s Association and the...
AIM Blog
Recognizing AIM’s February Advocate of the Month: Ann Sechrist
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
AIM Blog
Recognizing AIM’s January Advocate of the Month: Bertha Bullen
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Alzheimer's Association Welcomes U.S. FDA Approval of Lecanemab
Association Renews Urgent Call for CMS to Cover FDA-Approved Alzheimer’s Treatments CHICAGO, January 6, 2023 — The Alzheimer’s Association enthusiastically...
AIM Blog
A Look Back on the 117th Congress’ Actions to Address Alzheimer’s and Dementia
Thanks to our hardworking advocates and congressional champions, critical bipartisan policy priorities to address Alzheimer’s and dementia across the nation...
Press Release
Critical Alzheimer’s and Dementia Priorities Signed Into Law
Washington, D.C., December 29, 2022 – The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) commend the passage of the...